<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20100725004443N24</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-12-29</date_registration>
      <primary_sponsor>Shaheed Rajaie's Cardiovascular Medical and Research Center</primary_sponsor>
      <public_title>Effectiveness of continues care program on self efficacy and outcomes in patients with  cardiac shocker</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of continues care program on self efficacy and outcomes in patients with Implantable Cardioverter Defibrillator</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-12-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>154</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/4761</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Assignment of patients in two groups of test and control was done by Block Balanced Randomization (BBR) method. The Randomization Sequence was generated with using the free web site at http://www.randomization.com, Blinding description: When discharging the patient, the researcher trains on the research and its method. However, he does not make the patient aware of his group and the researcher is not the member of the staff and the hospital staff does not participate in the intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>The patient with an Implantable Cardioverter Defibrillator.</hc_freetext>
      <i_freetext>Intervention 1: Control group:This patients do not receive any intervention from the researcher and are discharged after receiving regular care at the facility. Intervention 2: Intervention group: The intervention includes two training sessions for 1.5 hours by the researcher and one month later, they go to the health-care center. In these sessions, the researcher trains the patients about the ability to take care of oneself after received shock, the way to register the shocks, the performance of the Device, their feeling when evacuating the energy and the required changes in lifestyle, the warning and follow-up and their relationship with the family members is explained. The researcher tells about the ways of reducing stress such as praying, relaxation, listening to music and distraction of mind and describes the solution based on the patient's will. After the second session,a training book is given to the patients including two parts. The first part explains the performance and equipment and the second part is about the experience of patients with Implantable Cardioverter Defibrillator. Finally, the patient's phone number is taken and the patient is followed from 8 am to 8 pm for 10 to 20 minutes based on the patient's need, verbal encouragement, responsiveness of the patient's questions, their current concerns, behavioral techniques to be consistent with the living conditions with heart shocker and relaxation in the book. In addition to phone follow-up, the participants in the intervention can access the researcher from morning to night and ask their questions.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zakerimoghadam Masoumeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nursing and Midwifery College of Tehran University, Easte Nosrat St., Tohid Square</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733171</zip>
        <telephone>+98 21 6692 7171</telephone>
        <email>zakerimo@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Haghjoo Majid</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shaheed Rajaie's Cardiovascular Medical and Rresearch Center, Niayesh Blvd., Vali-Asr Ave.,</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1996911151</zip>
        <telephone>+98 21 2392 2358</telephone>
        <email>majid.haghjoo@gmail.com</email>
        <affiliation>Shaheed Rajaie's Cardiovascular Medical and Rresearch Center</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being 20 to 80 years old
Being ability to read, write, and speak in Persian
Accessing phone call
Implanting Cardioverter Defibrillator for the first time</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Suffering from Cognitive Disorders
Suffering from Commorbidity results in hospitalization
Participation in other intervention program</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group:This patients do not receive any intervention from the researcher and are discharged after receiving regular care at the facility.</i_keyword>
      <i_keyword>Intervention group: The intervention includes two training sessions for 1.5 hours by the researcher and one month later, they go to the health-care center. In these sessions, the researcher trains the patients about the ability to take care of oneself after received shock, the way to register the shocks, the performance of the Device, their feeling when evacuating the energy and the required changes in lifestyle, the warning and follow-up and their relationship with the family members is explained. The researcher tells about the ways of reducing stress such as praying, relaxation, listening to music and distraction of mind and describes the solution based on the patient's will. After the second session,a training book is given to the patients including two parts. The first part explains the performance and equipment and the second part is about the experience of patients with Implantable Cardioverter Defibrillator. Finally, the patient's phone number is taken and the patient is followed from 8 am to 8 pm for 10 to 20 minutes based on the patient's need, verbal encouragement, responsiveness of the patient's questions, their current concerns, behavioral techniques to be consistent with the living conditions with heart shocker and relaxation in the book. In addition to phone follow-up, the participants in the intervention can access the researcher from morning to night and ask their questions.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Self-efficacy. Timepoint: Before the intervention, immediately after ending the intervention. Method of measurement: Self-efficacy  questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Anxiety. Timepoint: Before the intervention, immediately after ending the intervention. Method of measurement: Speil-berger State-Trait Anxiety Inventory.</sec_outcome>
      <sec_outcome>Number of received shocks. Timepoint: Immediately after ending the intervention. Method of measurement: patient report.</sec_outcome>
      <sec_outcome>Referrals outside of the plan to Medical centers. Timepoint: Immediately after ending the intervention. Method of measurement: patient report.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shaheed Rajaie's Cardiovascular Medical and Research Center</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-01-23</approval_date>
        <contact_name>Ethic commitee of Shaheed Rajaie's Cardiovascular Medical and Rresearch Center</contact_name>
        <contact_address>Shaheed Rajaie's Cardiovascular Medical and Rresearch Center, Niayesh Blvd., Vali-Asr Ave. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
